Assessing the Utility of Glycated Hemoglobin

Eberhardt, Mark S; Flegal, Katherine M

doi:10.2337/diacare.21.9.1578a

Article navigation

Letters: Comments and Responses| September 01 1998

Assessing the Utility of Glycated Hemoglobin

Mark S Eberhardt, PHD;

Mark S Eberhardt, PHD

Office of Analysis, Epidemiology, and Health Promotion, National Center for Health Statistics, Centers for Disease Control and Prevention

Hyattsville, Maryland

Search for other works by this author on:

This Site

PubMed

Google Scholar

Katherine M Flegal, PHD

Division of Health Examination Statistics, National Center for Health Statistics, Centers for Disease Control and Prevention

Hyattsville, Maryland

Search for other works by this author on:

This Site

PubMed

Google Scholar

Address correspondence to Mark S. Eberhardt, PhD, Office of Analysis, Epidemiology, and Health Promotion, National Center for Health Statistics, Centers for Disease Control and Prevention, 6525 Belcrest Rd., Room 730, Hyattsville, MD 20782.

Diabetes Care 1998;21(9):1578

https://doi.org/10.2337/diacare.21.9.1578a

Assessing the Utility of Glycated Hemoglobin

Article PDF first page preview

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

Assessing the Utility of Glycated Hemoglobin Free

Article PDF first page preview

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

This Feature Is Available To Subscribers Only

Assessing the Utility of Glycated Hemoglobin